Call_us
Cetirizine Dihydrochloride Tablet

Cetirizine Dihydrochloride Tablet

Product Details:

  • Application Commercial, Clinical, Hospital and Personal
  • Formulations Type General Drugs
  • Formulations Form Tablets
  • Gender/Age Group Adult
  • Storage Instructions Dry Place
  • Supply Ability : 100 Box Box Per Day
  • Click to view more
X

Price And Quantity

  • 100 Box
  • 400 INR

Product Specifications

  • Tablets
  • General Drugs
  • Commercial, Clinical, Hospital and Personal
  • Dry Place
  • Adult

Trade Information

  • Mundra and Mumbai
  • Cash Advance (CA), Cash in Advance (CID)
  • 100 Box Box Per Day
  • 3-30 Days
  • Yes
  • Sample costs shipping and taxes has to be paid by the buyer
  • Box and Carton
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

 

 Cetirizine Dihydrochloride 10mg

 Cetirizine Dihydrochloride tablet

 Cetirizine 10mg

 

Indications:
Perennial Allergic Rhinitis: Cetirizine Dihydrochloride syrup is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens
such as dust mites, animal dander and molds in children 6 to 23 months of age. Symptoms treated effectively include sneezing, rhinorrhea, postnasal discharge,
nasal pruritus, ocular pruritus, and tearing. Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
● Runny Nose
● Sneezing
● Itchy, Watery Eyes
● Itching Of The Nose Or Throat
Chronic Urticaria: Cetirizine Dihydrochloride syrup is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in
children 6 months to 5 years of age. It significantly reduces the occurrence, severity, and duration of hives and significantly reduces pruritus.


SCHWITZ BIOTECH

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



SCHWITZ BIOTECH All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.